165 related articles for article (PubMed ID: 24626568)
21. GSTP1 hypermethylation is associated with reduced protein expression, aggressive disease and prognosis in neuroblastoma.
Gumy-Pause F; Pardo B; Khoshbeen-Boudal M; Ansari M; Gayet-Ageron A; Sappino AP; Attiyeh EF; Ozsahin H
Genes Chromosomes Cancer; 2012 Feb; 51(2):174-85. PubMed ID: 22045684
[TBL] [Abstract][Full Text] [Related]
22. Stronger prognostic power of the CpG island methylator phenotype than methylation of individual genes in neuroblastomas.
Asada K; Watanabe N; Nakamura Y; Ohira M; Westermann F; Schwab M; Nakagawara A; Ushijima T
Jpn J Clin Oncol; 2013 Jun; 43(6):641-5. PubMed ID: 23619990
[TBL] [Abstract][Full Text] [Related]
23. Atypic SUMOylation of Nor1/NR4A3 regulates neural cell viability and redox sensitivity.
Gagnon J; Caron V; Gyenizse L; Tremblay A
FASEB J; 2021 Sep; 35(9):e21827. PubMed ID: 34383980
[TBL] [Abstract][Full Text] [Related]
24. Aberrant methylation of candidate tumor suppressor genes in neuroblastoma.
Hoebeeck J; Michels E; Pattyn F; Combaret V; Vermeulen J; Yigit N; Hoyoux C; Laureys G; De Paepe A; Speleman F; Vandesompele J
Cancer Lett; 2009 Jan; 273(2):336-46. PubMed ID: 18819746
[TBL] [Abstract][Full Text] [Related]
25. Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis.
Fedorova O; Petukhov A; Daks A; Shuvalov O; Leonova T; Vasileva E; Aksenov N; Melino G; Barlev NA
Oncogene; 2019 Mar; 38(12):2108-2122. PubMed ID: 30455429
[TBL] [Abstract][Full Text] [Related]
26. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA BRE-AS1 represses non-small cell lung cancer cell growth and survival via up-regulating NR4A3.
Zhang M; Wu J; Zhong W; Zhao Z; Liu Z
Arch Biochem Biophys; 2018 Dec; 660():53-63. PubMed ID: 30227111
[TBL] [Abstract][Full Text] [Related]
28. Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma.
Ikram F; Ackermann S; Kahlert Y; Volland R; Roels F; Engesser A; Hertwig F; Kocak H; Hero B; Dreidax D; Henrich KO; Berthold F; Nürnberg P; Westermann F; Fischer M
Mol Oncol; 2016 Feb; 10(2):344-59. PubMed ID: 26598443
[TBL] [Abstract][Full Text] [Related]
29. Identification of aberrant methylation regions in neuroblastoma by screening of tissue-specific differentially methylated regions.
Sugito K; Kawashima H; Uekusa S; Yoshizawa S; Hoshi R; Furuya T; Kaneda H; Hosoda T; Masuko T; Ohashi K; Ikeda T; Koshinaga T; Fujiwara K; Igarashi J; Ghosh S; Held WA; Nagase H
Pediatr Blood Cancer; 2013 Mar; 60(3):383-9. PubMed ID: 22911660
[TBL] [Abstract][Full Text] [Related]
30. Hypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.
Spitzwieser M; Entfellner E; Werner B; Pulverer W; Pfeiler G; Hacker S; Cichna-Markl M
BMC Cancer; 2017 Apr; 17(1):260. PubMed ID: 28403857
[TBL] [Abstract][Full Text] [Related]
31. The protective role of NR4A3 in acute myocardial infarction by suppressing inflammatory responses via JAK2-STAT3/NF-κB pathway.
Jiang Y; Feng YP; Tang LX; Yan YL; Bai JW
Biochem Biophys Res Commun; 2019 Oct; 517(4):697-702. PubMed ID: 31399192
[TBL] [Abstract][Full Text] [Related]
32. Identification of frequent differentially methylated region in sporadic bladder cancers.
Hasegawa R; Fujiwara K; Obinata D; Kawashima H; Shinojima Y; Igarashi J; Wang X; Ghosh S; Nagase H; Takahashi S
Urol Int; 2015; 94(4):479-84. PubMed ID: 25227574
[TBL] [Abstract][Full Text] [Related]
33. SMARCA2-NR4A3 is a novel fusion gene of extraskeletal myxoid chondrosarcoma identified by RNA next-generation sequencing.
Wei S; Pei J; von Mehren M; Abraham JA; Patchefsky AS; Cooper HS
Genes Chromosomes Cancer; 2021 Oct; 60(10):709-712. PubMed ID: 34124809
[TBL] [Abstract][Full Text] [Related]
34. Global MYCN transcription factor binding analysis in neuroblastoma reveals association with distinct E-box motifs and regions of DNA hypermethylation.
Murphy DM; Buckley PG; Bryan K; Das S; Alcock L; Foley NH; Prenter S; Bray I; Watters KM; Higgins D; Stallings RL
PLoS One; 2009 Dec; 4(12):e8154. PubMed ID: 19997598
[TBL] [Abstract][Full Text] [Related]
35. Hypermethylation-mediated regulation of CD44 gene expression in human neuroblastoma.
Yan P; Mühlethaler A; Bourloud KB; Beck MN; Gross N
Genes Chromosomes Cancer; 2003 Feb; 36(2):129-38. PubMed ID: 12508241
[TBL] [Abstract][Full Text] [Related]
36. Coexpression of NOR1 and SIX3 proteins in extraskeletal myxoid chondrosarcomas without detectable NR4A3 fusion genes.
Hisaoka M; Okamoto S; Yokoyama K; Hashimoto H
Cancer Genet Cytogenet; 2004 Jul; 152(2):101-7. PubMed ID: 15262426
[TBL] [Abstract][Full Text] [Related]
37. DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights.
Gómez S; Castellano G; Mayol G; Suñol M; Queiros A; Bibikova M; Nazor KL; Loring JF; Lemos I; Rodríguez E; de Torres C; Mora J; Martín-Subero JI; Lavarino C
Epigenomics; 2015 Oct; 7(7):1137-53. PubMed ID: 26067621
[TBL] [Abstract][Full Text] [Related]
38. NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes.
Deutsch AJA; Rinner B; Pichler M; Prochazka K; Pansy K; Bischof M; Fechter K; Hatzl S; Feichtinger J; Wenzl K; Frisch MT; Stiegelbauer V; Prokesch A; Krogsdam A; Sill H; Thallinger GG; Greinix HT; Wang C; Beham-Schmid C; Neumeister P
Cancer Res; 2017 May; 77(9):2375-2386. PubMed ID: 28249906
[TBL] [Abstract][Full Text] [Related]
39. Genome-wide methylation profiling identifies novel methylated genes in neuroblastoma tumors.
Olsson M; Beck S; Kogner P; Martinsson T; Carén H
Epigenetics; 2016; 11(1):74-84. PubMed ID: 26786290
[TBL] [Abstract][Full Text] [Related]
40. Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomas.
Kiss NB; Kogner P; Johnsen JI; Martinsson T; Larsson C; Geli J
BMC Med Genet; 2012 Sep; 13():83. PubMed ID: 22984959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
